Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Transcriptional control of lung alveolar type 1 cell development and maintenance by NK homeobox 2-1.

Little DR, Gerner-Mauro KN, Flodby P, Crandall ED, Borok Z, Akiyama H, Kimura S, Ostrin EJ, Chen J.

Proc Natl Acad Sci U S A. 2019 Oct 8;116(41):20545-20555. doi: 10.1073/pnas.1906663116. Epub 2019 Sep 23.

PMID:
31548395
2.

Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma.

Hu X, Fujimoto J, Ying L, Fukuoka J, Ashizawa K, Sun W, Reuben A, Chow CW, McGranahan N, Chen R, Hu J, Godoy MC, Tabata K, Kuroda K, Shi L, Li J, Behrens C, Parra ER, Little LD, Gumbs C, Mao X, Song X, Tippen S, Thornton RL, Kadara H, Scheet P, Roarty E, Ostrin EJ, Wang X, Carter BW, Antonoff MB, Zhang J, Vaporciyan AA, Pass H, Swisher SG, Heymach JV, Lee JJ, Wistuba II, Hong WK, Futreal PA, Su D, Zhang J.

Nat Commun. 2019 Jul 5;10(1):2978. doi: 10.1038/s41467-019-10877-8.

3.

Continuous Objective Assessment of Near Work.

Williams R, Bakshi S, Ostrin EJ, Ostrin LA.

Sci Rep. 2019 May 6;9(1):6901. doi: 10.1038/s41598-019-43408-y.

4.

Transcriptomic profiles of retinal ganglion cells are defined by the magnitude of intraocular pressure elevation in adult mice.

Park YH, Snook JD, Ostrin EJ, Kim S, Chen R, Frankfort BJ.

Sci Rep. 2019 Feb 22;9(1):2594. doi: 10.1038/s41598-019-39141-1.

5.

COPD-Type lung inflammation promotes K-ras mutant lung cancer through epithelial HIF-1α mediated tumor angiogenesis and proliferation.

De la Garza MM, Cumpian AM, Daliri S, Castro-Pando S, Umer M, Gong L, Khosravi N, Caetano MS, Ramos-Castañeda M, Flores AG, Beltran EC, Tran HT, Tuvim MJ, Ostrin EJ, Dickey BF, Evans CM, Moghaddam SJ.

Oncotarget. 2018 Aug 31;9(68):32972-32983. doi: 10.18632/oncotarget.26030. eCollection 2018 Aug 31.

6.

Blood based biomarkers beyond genomics for lung cancer screening.

Hanash SM, Ostrin EJ, Fahrmann JF.

Transl Lung Cancer Res. 2018 Jun;7(3):327-335. doi: 10.21037/tlcr.2018.05.13. Review.

7.

IL22 Promotes Kras-Mutant Lung Cancer by Induction of a Protumor Immune Response and Protection of Stemness Properties.

Khosravi N, Caetano MS, Cumpian AM, Unver N, De la Garza Ramos C, Noble O, Daliri S, Hernandez BJ, Gutierrez BA, Evans SE, Hanash S, Alekseev AM, Yang Y, Chang SH, Nurieva R, Kadara H, Chen J, Ostrin EJ, Moghaddam SJ.

Cancer Immunol Res. 2018 Jul;6(7):788-797. doi: 10.1158/2326-6066.CIR-17-0655. Epub 2018 May 15.

8.

β-Catenin maintains lung epithelial progenitors after lung specification.

Ostrin EJ, Little DR, Gerner-Mauro KN, Sumner EA, Ríos-Corzo R, Ambrosio E, Holt SE, Forcioli-Conti N, Akiyama H, Hanash SM, Kimura S, Huang SXL, Chen J.

Development. 2018 Mar 9;145(5). pii: dev160788. doi: 10.1242/dev.160788.

9.

Plasma-derived extracellular vesicle proteins as a source of biomarkers for lung adenocarcinoma.

Vykoukal J, Sun N, Aguilar-Bonavides C, Katayama H, Tanaka I, Fahrmann JF, Capello M, Fujimoto J, Aguilar M, Wistuba II, Taguchi A, Ostrin EJ, Hanash SM.

Oncotarget. 2017 Sep 8;8(56):95466-95480. doi: 10.18632/oncotarget.20748. eCollection 2017 Nov 10.

10.

Reduced IL-6 levels and tumor-associated phospho-STAT3 are associated with reduced tumor development in a mouse model of lung cancer chemoprevention with myo-inositol.

Unver N, Delgado O, Zeleke K, Cumpian A, Tang X, Caetano MS, Wang H, Katayama H, Yu H, Szabo E, Wistuba II, Moghaddam SJ, Hanash SM, Ostrin EJ.

Int J Cancer. 2018 Apr 1;142(7):1405-1417. doi: 10.1002/ijc.31152. Epub 2017 Dec 23.

11.

MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway.

Tripathi SC, Fahrmann JF, Celiktas M, Aguilar M, Marini KD, Jolly MK, Katayama H, Wang H, Murage EN, Dennison JB, Watkins DN, Levine H, Ostrin EJ, Taguchi A, Hanash SM.

Cancer Res. 2017 Aug 15;77(16):4414-4425. doi: 10.1158/0008-5472.CAN-16-2874. Epub 2017 Jun 23.

12.

Role of CPS1 in Cell Growth, Metabolism and Prognosis in LKB1-Inactivated Lung Adenocarcinoma.

Çeliktas M, Tanaka I, Tripathi SC, Fahrmann JF, Aguilar-Bonavides C, Villalobos P, Delgado O, Dhillon D, Dennison JB, Ostrin EJ, Wang H, Behrens C, Do KA, Gazdar AF, Hanash SM, Taguchi A.

J Natl Cancer Inst. 2017 Mar 1;109(3):1-9. doi: 10.1093/jnci/djw231.

13.

The Emerging Role of B Cells in Tumor Immunity.

Tsou P, Katayama H, Ostrin EJ, Hanash SM.

Cancer Res. 2016 Oct 1;76(19):5597-5601. Epub 2016 Sep 15. Review.

14.

IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung Cancer.

Caetano MS, Zhang H, Cumpian AM, Gong L, Unver N, Ostrin EJ, Daliri S, Chang SH, Ochoa CE, Hanash S, Behrens C, Wistuba II, Sternberg C, Kadara H, Ferreira CG, Watowich SS, Moghaddam SJ.

Cancer Res. 2016 Jun 1;76(11):3189-99. doi: 10.1158/0008-5472.CAN-15-2840. Epub 2016 Apr 1.

15.

Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome.

Tripathi SC, Peters HL, Taguchi A, Katayama H, Wang H, Momin A, Jolly MK, Celiktas M, Rodriguez-Canales J, Liu H, Behrens C, Wistuba II, Ben-Jacob E, Levine H, Molldrem JJ, Hanash SM, Ostrin EJ.

Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):E1555-64. doi: 10.1073/pnas.1521812113. Epub 2016 Feb 29.

16.

Deciphering the complexity of the cancer proteome for diagnostic applications.

Hanash S, Taguchi A, Wang H, Ostrin EJ.

Expert Rev Mol Diagn. 2016;16(4):399-405. doi: 10.1586/14737159.2016.1135738. Epub 2016 Feb 17. Review.

PMID:
26694525
17.

The development and plasticity of alveolar type 1 cells.

Yang J, Hernandez BJ, Martinez Alanis D, Narvaez del Pilar O, Vila-Ellis L, Akiyama H, Evans SE, Ostrin EJ, Chen J.

Development. 2016 Jan 1;143(1):54-65. doi: 10.1242/dev.130005. Epub 2015 Nov 19.

18.

Airway epithelial miRNA expression is altered in asthma.

Solberg OD, Ostrin EJ, Love MI, Peng JC, Bhakta NR, Hou L, Nguyen C, Solon M, Nguyen C, Barczak AJ, Zlock LT, Blagev DP, Finkbeiner WE, Ansel KM, Arron JR, Erle DJ, Woodruff PG.

Am J Respir Crit Care Med. 2012 Nov 15;186(10):965-74. doi: 10.1164/rccm.201201-0027OC. Epub 2012 Sep 6.

19.

The tissue's the issue.

Zeidner JF, Ostrin EJ, Sydnor E, Fine D, Sperati CJ.

Am J Med. 2010 May;123(5):420-2. doi: 10.1016/j.amjmed.2010.01.008. No abstract available.

PMID:
20399317
20.

Genome-wide identification of direct targets of the Drosophila retinal determination protein Eyeless.

Ostrin EJ, Li Y, Hoffman K, Liu J, Wang K, Zhang L, Mardon G, Chen R.

Genome Res. 2006 Apr;16(4):466-76. Epub 2006 Mar 13.

21.

Dual regulation and redundant function of two eye-specific enhancers of the Drosophila retinal determination gene dachshund.

Pappu KS, Ostrin EJ, Middlebrooks BW, Sili BT, Chen R, Atkins MR, Gibbs R, Mardon G.

Development. 2005 Jun;132(12):2895-905.

22.

Structure-function analysis of the Drosophila retinal determination protein Dachshund.

Tavsanli BC, Ostrin EJ, Burgess HK, Middlebrooks BW, Pham TA, Mardon G.

Dev Biol. 2004 Aug 1;272(1):231-47.

23.

Eyes absent represents a class of protein tyrosine phosphatases.

Rayapureddi JP, Kattamuri C, Steinmetz BD, Frankfort BJ, Ostrin EJ, Mardon G, Hegde RS.

Nature. 2003 Nov 20;426(6964):295-8.

PMID:
14628052
24.

A genome-wide search for synaptic vesicle cycle proteins in Drosophila.

Lloyd TE, Verstreken P, Ostrin EJ, Phillippi A, Lichtarge O, Bellen HJ.

Neuron. 2000 Apr;26(1):45-50.

25.

Myocardial protection with high-dose beta-blockade in acute myocardial ischemia.

Geissler HJ, Davis KL, Laine GA, Ostrin EJ, Mehlhorn U, Hekmat K, Warters RD, Allen SJ.

Eur J Cardiothorac Surg. 2000 Jan;17(1):63-70.

PMID:
10735414

Supplemental Content

Loading ...
Support Center